AbLeads attended this year’s Meet2Win oncology business convention organized by MATWIN, in Bordeaux. This turned out to be a great opportunity to meet major actors of the oncology field coming from biotechs, pharmas, startups, clinics and academic institutions all over Europe.
Aside from the very interesting talks and debates focusing this year on immuno-oncology and precision medicine, we have had the pleasant surprise to receive numerous invitations to one-to-one meetings to present and discuss our project. Although we could not accept all meeting requests, we did our best to attend as many as possible all. As a result, we are glad to report that the AbLeads project generated great interest. We have received very positive feedback and helpful advice from key opinion leaders in immunology, pharmacology and clinical oncology. Besides, we have identified promising potential partners that could bring their expertise and support at various stages of the project.
Do you like our project? Please Donate now to help us develop our unique personalized anti-cancer antibody development technology!
Please share this so that others can discover our project!